Test Price
2,800 AED✅ Home Collection Available
GMPPA Gene Alacrima, Achalasia, and Mental Retardation Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GMPPA لمتلازمة نقص الدموع وتعذر الارتخاء المريئي والتخلف العقلي بتقنية التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
✓ Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy.
✓ Clinical Guidance: Telephonic Post‑Test Clinical Guidance for Result Interpretation.
✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
يُقدم هذا التحليل الجيني الشامل لجين GMPPA تشخيصًا دقيقًا لمتلازمة نقص الدموع وتعذر الارتخاء المريئي والتخلف العقلي، معتمدًا من هيئة الصحة بدبي وموافقًا للقوانين الاتحادية لدولة الإمارات.
Test Overview
The GMPPA Genetic Test comprehensively sequences the entire GMPPA gene, enabling precise diagnosis of the rare Alacrima, Achalasia, and Mental Retardation (AAMR) syndrome. This advanced genetic analysis empowers pediatricians, clinical geneticists, and pediatric gastroenterologists to tailor lifelong management and genetic counselling for affected children and their families.
يقوم هذا الاختبار بتسلسل جين GMPPA بالكامل، مما يتيح تشخيصًا دقيقًا لمتلازمة نقص الدموع وتعذر الارتخاء المريئي والتخلف العقلي، ويساعد الأطباء في توجيه الرعاية المتخصصة.
| Feature | Our Test (GMPPA NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% analytical sensitivity & specificity; full gene coverage including deep intronic regions | ~95% sensitivity; limited to coding exons; may miss large deletions/duplications |
| Methodology | Next‑Generation Sequencing (NGS) with advanced bioinformatics and copy‑number analysis | Bi‑directional Sanger sequencing of exons only |
| Turnaround Time | 3 to 4 Weeks (guaranteed) | 6 to 8 Weeks (variable) |
Physician Insight & Safety Protocol
“As a clinician deeply involved in dysmorphology, I remind families that a genetic diagnosis is a compass, not a verdict. The GMPPA test illuminates the path for targeted surveillance and support, but each patient’s clinical picture must guide therapeutic decisions. Please never alter any treatment without direct consultation with your managing physician.”
— Dr. PRABHAKAR REDDY, DHA License 61713011, Consultant Pediatrician
Medication Warning: Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace ongoing clinical management.
Safety & Exclusion Criteria
- Exclusion: Infants under 3 months for capillary collection; individuals with active systemic infection requiring immediate acute care.
- Pre‑Test Requirement: Genetic counselling session and signed informed consent from legal guardian (mandatory per UAE CDS Law 2026 for minors).
- Emergency Red Flags: If the patient experiences severe dehydration, aspiration pneumonia, or respiratory distress, seek emergency medical attention immediately – do not wait for test results.
Patient FAQ & Clinical Guidance
1. What does the GMPPA Genetic Test detect?
NGS-based GMPPA gene testing detects pathogenic variants linked to alacrima, achalasia, and intellectual disability syndrome. The reads every coding and splice-region nucleotide, identifying missense, nonsense, small indels, and copy-number changes that cause AAMR syndrome, providing a definitive molecular diagnosis when clinical features suggest this condition.
يكشف اختبار جين GMPPA بتقنية التسلسل الجيني عن الطفرات المسببة لمتلازمة نقص الدموع وتعذر الارتخاء المريئي والإعاقة الذهنية، مما يؤكد التشخيص الجزيئي للحالة.
2. How is sample collection performed?
Sample collection requires a single blood draw, extracted DNA, or one drop of blood on an FTA card. Our VIP mobile phlebotomy team arrives at your home between 8 AM and 11 PM, uses a hospital‑grade cold chain, and ensures the specimen reaches our ISO‑certified lab within 4 hours, preserving DNA integrity for highest accuracy.
يتم جمع العينة عبر سحب دم بسيط أو بقعة دم على بطاقة FTA، بواسطة فريق التمريض المنزلي المعتمد، مع ضمان النقل المبرد للحفاظ على الحمض النووي.
3. What does a positive result mean?
A positive result confirms a disease-causing mutation in the GMPPA gene, establishing the diagnosis of alacrima, achalasia, and mental retardation syndrome. This enables personalized surveillance for achalasia complications, tear substitutes for alacrima, and early intervention programs for developmental support, while guiding family genetic counselling.
تؤكد النتيجة الإيجابية وجود طفرة ممرضة في جين GMPPA، مما يثبت تشخيص المتلازمة ويوجه خطة الرعاية متعددة التخصصات والاستشارة الوراثية للعائلة.
Compliance: Federal Decree-Law No. 41 of 2024 (Art. 87) · UAE CDS Law 2026 (Minors) · UAE PDPL Data Privacy
ISO 9001:2015 Certified – Cert: INT/EGQ/2509DA/3139 · Facility License: 9834453
Support: WhatsApp +971 54 548 8731
Home Collection: 8 AM – 11 PM, 7 days
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians